Evidence map›Paper›PMID 42213377›Full record

ArticleMolecular diversity2026

Rational design of triazole tyrosinase inhibitors via integrated free energy calculations.

Nathália Luiza Oliveira Costa, Cláudio Nahum Alves, Lucas Sousa Martins, José Rogério A Silva

Abstract read
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nathália Luiza Oliveira CostaLaboratory of Computer Modeling of Molecular Biosystems (CompMBio), Federal University of Pará, Belém, Pará, 66075-110, Brazil.ORCID http://orcid.org/0009-0007-2299-6688
Cláudio Nahum AlvesLaboratório de Planejamento e Desenvolvimento de Fármacos, Instituto de Ciências Exatas e Naturais, Universidade Federal do Pará, Belém, Pará, 66075- 110, Brazil.ORCID http://orcid.org/0000-0001-6576-4229
Lucas Sousa MartinsLaboratory of Computer Modeling of Molecular Biosystems (CompMBio), Federal University of Pará, Belém, Pará, 66075-110, Brazil.ORCID http://orcid.org/0000-0002-8580-2736
José Rogério A SilvaLaboratory of Computer Modeling of Molecular Biosystems (CompMBio), Federal University of Pará, Belém, Pará, 66075-110, Brazil. rogerio@ufpa.br.ORCID http://orcid.org/0000-0003-2310-5107

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tyrosinase (TYR) is a copper-containing metalloenzyme involved in melanin biosynthesis and is an important target in the development of treatments for hyperpigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and melanoma. Among the scaffold classes investigated for TYR inhibition, 1,2,4-triazole derivatives have attracted increasing interest. In this study, we evaluated a structurally diverse series of triazole derivatives using an integrated computational workflow that included absorption, distribution, metabolism, excretion and toxicity (ADMET) profiling, molecular docking, molecular dynamics (MD) simulations, and binding free energy calculations based on Linear Interaction Energy (LIE) and Free Energy Perturbation (FEP). Using Bacillus megaterium TYR as the model enzyme, the triazole derivatives generally produced more favorable docking scores than kojic acid and established recurring interactions with hydrophobic residues such as Met215, Val217, Ala221, and Phe227, as well as hydrogen-bonding contacts with Gly216. The free energy calculations reproduced the experimental binding affinities with high accuracy (FEP: R² = 0.91, MAE = 0.20 kcal/mol; LIE: R² = 0.93, MAE = 0.54 kcal/mol). Residue-level energy analysis indicated that interactions involving Arg209, Gly216 and Val218 play a major role in ligand binding across the series, with aromatic and halogenated substituents favoring stronger van der Waals contacts in this region. Overall, these results provide a consistent structural and energetic framework for understanding triazole-based TYR inhibition and may support the rational design of improved inhibitors for cosmetic and therapeutic applications.

Indexed as

Drug DesignEnzyme InhibitorsMonophenol MonooxygenaseTriazolesBacillus megateriumMolecular Docking SimulationMolecular Dynamics SimulationThermodynamicsEnzyme InhibitorsMonophenol MonooxygenaseTriazolesDrug designFree energy perturbationHyperpigmentation.Linear interaction energyMolecular dynamicsTyrosinase Inhibition

Identifiers

PMID42213377
PMCPMC13635027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.